HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Inhibitor factors in the serum of patients with the AIDS-related complex].

Abstract
The data on the presence of factors blocking the reaction of E-rosette formation and leukocyte chemotaxis in the blood sera of patients with AIDS-related complex (ARC) and HIV-positive donors are presented. Most frequently the blocking of E-rosette formation coincided with the presence of a inhibiting effect on the migration capacity of leukocytes. This blocking activity was not linked with the presence of C-reactive protein in the circulation stream. The treatment of ARC patients with plasmapheresis and/or travolol was accompanied either by the disappearance of blocking activity or by the appearance of activity stimulating E-rosette formation.
AuthorsB V Pinegin, M Z Saidov, O F Eremina, A M Borisova, R M Khaitov
JournalZhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) Issue 2 Pg. 26-7 (Feb 1991) ISSN: 0372-9311 [Print] Russia (Federation)
Vernacular TitleIngibitornye faktory v syvorotke bol'nykh so SPID-assotsiirovannym kompleksom.
PMID1867028 (Publication Type: English Abstract, Journal Article)
Chemical References
  • travolol
  • Penicillamine
Topics
  • AIDS-Related Complex (immunology, therapy)
  • Adolescent
  • Adult
  • Cell Migration Inhibition
  • Female
  • HIV Seropositivity (immunology, therapy)
  • HIV-1
  • Humans
  • Immune Tolerance (immunology)
  • Male
  • Middle Aged
  • Penicillamine (analogs & derivatives, therapeutic use, toxicity)
  • Plasmapheresis
  • Rosette Formation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: